Showing results (7541-7550 of 10,388) with videos related to
Sort By:
Pageof 1,039
Vaccines|May 26, 2026
Exploring the Vaccine Adjuvant Effect and Mechanism of Epimedium Using Network Pharmacology, Molecular Docking, and Molecular Dynamics SimulationsMeng Tang, Anni Zhao, Yun Yang, et al.Vaccines|May 26, 2026
Impact of the COVID-19 Pandemic on HPV Vaccination in Low- and Middle-Income Countries: A Scoping ReviewJoyce Omondi, Robert Ambogo, Candy Ochieng, et al.Vaccines|May 26, 2026
Enhancing Capsid Stability of a Foot-and-Mouth Disease Virus Vaccine Strain Through VP1-Directed Chimeric Design While Preserving AntigenicityJong Sook Jin, Sun Young Park, Jae Young Kim, et al.Vaccines|May 26, 2026
Bordetella pertussis Infection: From Immune Pathogenesis to Next-Generation VaccinesVasiliki E Georgakopoulou, Vassiliki C PitirigaVaccines|May 26, 2026
Bridging the Gap: Disparities in HPV Vaccine Uptake Between In-School and Out-of-School Girls Following a Demand Generation Intervention in Ethiopia: A Cross-Sectional StudyTelake Azale, Tewodros Alemayehu, Hiwot Tadesse Belay, et al.Vaccines|May 26, 2026
Vaccines as Global Health Security Infrastructure: Insights from a Descriptive Analysis of Vaccines Europe Members' Clinical PipelinesCharlotte Vernhes, Kateryna Khmilevska, Alexis Caron, et al.Vaccines|May 26, 2026
Intranasal Immunization with Live-Attenuated RSV-Vectored SARS-CoV-2 Vaccines Elicits Antigen-Specific Systemic and Mucosal Immunity and Protects Against Viral Challenge and Natural InfectionDavide Botta, Michael D Schultz, Aaron Silva-Sanchez, et al.Vaccines|May 26, 2026
Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United StatesKlodeta Kura, John C Lang, Dawei Wang, et al.Vaccines|May 26, 2026
Uptake of Shingles, Influenza, COVID-19 and Pneumococcal Vaccination in Patients with Inflammatory Arthritis: A Three-Centre StudyKrishika Balakrishnan, Lozan Hussein Mahmood Zangana, Moyinoluwa Rachel Ajayi, et al.Vaccines|May 26, 2026
Potential to Avert Additional Influenza Burden in the United States with Use of Adjuvanted vs. Standard Influenza Vaccines in Individuals 50-64 Years of AgeIan McGovern, Roberto Flores, Mendel D M HaagPageof 1,039